OverviewChartTechnicalNewsTraderScreen

Aptevo Therapeutics Inc/  US03835L3069  /

NASDAQ
13/06/2024  22:00:00 Chg. -0.0477 Volume Bid12:01:57 Ask12:01:57 High Low
0.7810USD -5.76% 79,516
Turnover: 51,813.2306		 0.7600Bid Size: 100 0.8300Ask Size: 300 0.8100 0.7604
GlobeNewswire 23/03/2022 Emergent BioSolutions Provides Corporate Governance Update
GlobeNewswire 02/11/2021 BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
GlobeNewswire 16/06/2021 Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021
GlobeNewswire 10/03/2021 Roth Capital Partners 33rd Annual Conference to be held Virtually March 15-17, 2021
GlobeNewswire 01/03/2021 Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
GlobeNewswire 03/11/2020 iBio Announces Appointment of Randy J. Maddux as Chief Operating Officer
GlobeNewswire 26/08/2020 Emergent BioSolutions Announces Appointment of Marvin White to the Company’s Board of Directors
GlobeNewswire 22/05/2020 Medexus Provides an Update on the IXINITY® Acquisition and its Overall Business in the COVID-19 Envi...
GlobeNewswire 20/04/2020 Zogenix Appoints Shawnte Mitchell as Executive Vice President, General Counsel & Secretary
GlobeNewswire 28/02/2020 Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®
GlobeNewswire 06/12/2019 Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogen...
GlobeNewswire 08/11/2019 Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Soc...
GlobeNewswire 07/11/2019 Aptevo Therapeutics Reports Third Quarter 2019 Financial Results
GlobeNewswire 03/10/2019 Aptevo Therapeutics Provides Corporate and Pipeline Update
GlobeNewswire 09/08/2019 Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
GlobeNewswire 07/08/2019 Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International Limited
GlobeNewswire 25/07/2019 Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials
GlobeNewswire 01/07/2019 aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members
GlobeNewswire 21/06/2019 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market 2019
GlobeNewswire 09/05/2019 Aptevo Therapeutics Reports First Quarter 2019 Financial Results
GlobeNewswire 23/04/2019 United States Biosimilars Market 2019-2025 Dosage, Price & Clinical Pipeline Outlook - A $5 Billion ...
GlobeNewswire 18/04/2019 Research Report Identifies Fastenal, Ideal Power, Fuel Tech, CTI BioPharma, Aptevo Therapeutics, and...
GlobeNewswire 15/04/2019 Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
GlobeNewswire 02/04/2019 Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Associ...
GlobeNewswire 25/03/2019 Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Asso...